BOBULSKY SUSAN Insider Trades

Insider Trading History

Track insider trading activity for BOBULSKY SUSAN. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.3M 406,288 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.7k 487 shares
$22.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.32M 406,775 shares
Last Trade
Jun 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 5,000 shares
$20.50
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.43M 411,775 shares
Last Trade
Jun 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$95k 5,000 shares
$19.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.54M 416,775 shares
Last Trade
Jun 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$198k 11,000 shares
$18.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.8M 427,775 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$544k 41,338 shares
$13.17
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $10.7M 469,113 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 62,500 shares
$16.44
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $9.31M 406,613 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$976k 59,375 shares
$16.44
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $7.95M 347,238 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$209k 26,023 shares
$8.03
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $8.55M 373,261 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 180,029 shares
$8.12
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $5.8M 253,290 shares
Last Trade
Oct 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.3k 5,000 shares
$5.25
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $0 0 shares
Last Trade
Oct 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.3k 5,000 shares
$5.25
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $5.85M 255,265 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.7k 12,991 shares
$3.44
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $5.98M 261,281 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$796k 199,549 shares
$3.99
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $2.94M 128,302 shares
Last Trade
Jan 25, 2024 Sale
$269k 67,224 shares
$4.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $210k 9,158 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 9,158 shares
$43.68
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $524k 22,894 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 22,894 shares
$43.68
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $573k 25,000 shares
Last Trade
Dec 10, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.38M 25,000 shares
$55.23
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $687k 30,000 shares
Last Trade
Dec 10, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.38M 25,000 shares
$55.23
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $0 0 shares
Last Trade
Dec 10, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 25,000 shares
$55.00
$22.90
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $0 0 shares
Last Trade
Sep 29, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$500k 10,000 shares
$50.00
$22.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up